Upgrade to SI Premium - Free Trial

RBC Capital Upgrades Gilead Sciences (GILD) to Top Pick; 'Valuation Disconnect Too Big To Ignore'

July 29, 2019 6:36 AM
RBC Capital analyst Brian Abrahams upgraded Gilead Sciences (NASDAQ: GILD) from Outperform to Top Pick with a price target of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Upgrades Upgrades

Next Articles